Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.

However, the interaction between hs-cTnT level (elevated versus normal) and treatment group was borderline significant for the composite end point of death, stroke, or HFH ( P interaction =0.06) and significant for the composite of death or HFH ( P interaction =0.04) and HFH alone ( P interaction =0.03; Figure 3 ).

also in 11,409 other papers

There were no significant interactions (although some were of borderline significance) on the basis of the number of elevated biomarkers and treatment group with respect to outcomes ( Figure S7 ).

also in 2,624 other papers